Higher long-term glycemic exposure and the presence of microvascular complications are significantly associated with an elevated risk for #sleep disturbances among older patients with type 1 #diabetes.
endocrinologyadvisor.com/new…
48
Dual-hormone fully closed-loop therapy improves time in the target #glucose range for adults with type 1 #diabetes.
endocrinologyadvisor.com/new…
60
3 #T1D stats every HCP should know:
🔹 Youth incidence rising up to 4.4%/yr in minority groups
🔹 Immunotherapy delays Stage 3 onset by ~2 yrs
🔹 ~5 in 1,000 US adults live with T1D[cite: 5]
Read the full factsheet here: bit.ly/4BAqbn7
#DiabetesCare #Endocrinology
3
103
Higher #menopause proteomic scores were consistently associated with faster cognitive decline and an increased risk for #Alzheimer disease and dementia in later life.
endocrinologyadvisor.com/new…
54
Treatment with #GLP1 receptor agonists and sodium-glucose cotransporter 2 inhibitors provides significant renoprotection in patients with type 2 #diabetes with vs without albuminuria.
endocrinologyadvisor.com/new…
53
Patients with type 2 #diabetes should sustain #smoking cessation for nearly a decade to achieve a progressive and significant reduction in risk of developing nephropathy, retinopathy, and neuropathy
endocrinologyadvisor.com/new…
86
Weekly administration of #retatrutide yields substantial weight reduction and alleviates obesity-related complications, such as knee osteoarthritis and obstructive sleep apnea (#OSA), in patients without diabetes.
endocrinologyadvisor.com/new…
1
86
High-dose and long-term oral #MenopausalHormoneTherapy elevate risk of venous and arterial thrombotic events, while transdermal formulations demonstrate a favorable #cardiovascular safety profile
endocrinologyadvisor.com/new…
67
As off-label #testosterone prescriptions for women have surged, researchers evaluated recent trends in off-label testosterone prescribing and #cardiovascular risk profiles among women in the US.
endocrinologyadvisor.com/fea…
71
#Semaglutide significantly reduced the risk of major #kidney complications and slowed the annual decline in estimated glomerular filtration rate among patients with cardio-kidney-metabolic disease
endocrinologyadvisor.com/new…
83
Treatment with #semaglutide significantly reduced body weight, waist circumference, and visceral fat mass while improving glycemic control in Asian adults meeting criteria for overweight or #obesity.
endocrinologyadvisor.com/new…
71
Multi-organ care is transforming #CKM management. Join @NACEonline on Oct 24 @ 9 AM ET for a live broadcast on 2026 CKM guidelines, amylin in obesity/T2D, severe HTG, & MASLD/MASH.
Earn up to 4.5 free CME credits!
Register: bit.ly/4iaE5TL
#FreeCME #Endocrinology
1
87
In #insulin-naive patients with #T2D, once-weekly icodec plus semaglutide vs daily insulin glargine U100 demonstrated superior HbA1c reductions, promoted weight loss, and lower incidence of hypoglycemia.
endocrinologyadvisor.com/new…
87
The American College of Obstetricians and Gynecologists (#ACOG) released updated clinical guidelines expanding treatment options for #menopause-related symptoms.
endocrinologyadvisor.com/new…
2
126
Despite higher per-person spending, enrollment in #Medicare Advantage vs original Medicare did not yield better cardiometabolic outcomes or reduce health-related social needs for adults with #T2D
endocrinologyadvisor.com/new…
66
Among patients with #obesity and resistant hypertension, fourth-line treatment with #GLP1 RAs is associated with favorable cardiovascular disease and renal protection.
endocrinologyadvisor.com/new…
77
The clinical course, onset time, and complication risk for #mitochondrial #diabetes are heavily dictated by specific genetic variants, particularly the m.3243A>G genotype.
endocrinologyadvisor.com/new…
59
The increased susceptibility to cognitive decline and Alzheimer disease observed in women with #PMOS is primarily mediated by underlying #metabolic dysfunctions such as insulin resistance and obesity.
endocrinologyadvisor.com/new…
78
Although an intensive hybrid lifestyle intervention did not significantly increase overall #WeightLoss in adults with #obesity, adherence to the program showed notable cardiometabolic improvements among patients.
endocrinologyadvisor.com/new…
64
Threshold alerts on continuous glucose monitors increased time in range and reduced time above range for hospitalized patients with #diabetes, though adding predictive alerts yielded no further #glycemic improvements.
endocrinologyadvisor.com/new…
57




